Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith van Dalem

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
International Journal of Clinical Pharmacy|January 25, 2012
Interventions promoting adherence to cardiovascular medicinesJudith van Dalem, Ines Krass, Parisa Aslani
Hepatology (Baltimore, Md.)|June 15, 2021
Thiazolidinediones and Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Nonalcoholic Fatty Liver Disease: A Cohort StudyJudith van Dalem, Johanna H M Driessen, Andrea M Burden, et al.
Diabetes Research and Clinical Practice|April 24, 2021
Determinants of treatment modification before and after implementation of the updated 2015 NICE guideline on type 2 diabetes: A retrospective cohort studyJudith van Dalem, Martijn C G J Brouwers, Andrea M Burden, et al.
Diabetes, Obesity & Metabolism|November 25, 2017
Risk of a first-ever acute myocardial infarction and all-cause mortality with sulphonylurea treatment: A population-based cohort studyJudith van Dalem, Martijn C G J Brouwers, Coen D A Stehouwer, et al.
BMJ (Clinical Research Ed.)|July 15, 2016
Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort studyJudith van Dalem, Martijn C G J Brouwers, Coen D A Stehouwer, et al.
Diabetes Research and Clinical Practice|July 16, 2022
Use of sodium-glucose co-transporter 2 inhibitors, changes in body mass index and risk of fracture: A population-based cohort studyJudith van Dalem, Nikki C C Werkman, Joop P van den Bergh, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
International Journal of Clinical Pharmacy|January 25, 2012
Interventions promoting adherence to cardiovascular medicinesJudith van Dalem, Ines Krass, Parisa Aslani
Hepatology (Baltimore, Md.)|June 15, 2021
Thiazolidinediones and Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Nonalcoholic Fatty Liver Disease: A Cohort StudyJudith van Dalem, Johanna H M Driessen, Andrea M Burden, et al.
Diabetes Research and Clinical Practice|April 24, 2021
Determinants of treatment modification before and after implementation of the updated 2015 NICE guideline on type 2 diabetes: A retrospective cohort studyJudith van Dalem, Martijn C G J Brouwers, Andrea M Burden, et al.
Diabetes, Obesity & Metabolism|November 25, 2017
Risk of a first-ever acute myocardial infarction and all-cause mortality with sulphonylurea treatment: A population-based cohort studyJudith van Dalem, Martijn C G J Brouwers, Coen D A Stehouwer, et al.
BMJ (Clinical Research Ed.)|July 15, 2016
Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort studyJudith van Dalem, Martijn C G J Brouwers, Coen D A Stehouwer, et al.
Diabetes Research and Clinical Practice|July 16, 2022
Use of sodium-glucose co-transporter 2 inhibitors, changes in body mass index and risk of fracture: A population-based cohort studyJudith van Dalem, Nikki C C Werkman, Joop P van den Bergh, et al.
Pageof 1